Harvard researchers have 3D printed the first-ever “organ-on-a-chip” with integrated sensors.
These organs-on-chips, also known as microphysiological systems, have great potential for in vitro tissue engineering and drug screening research.
The development is also a promising substitute to traditional animal testing, which could result in saving innumerable lives lost in clinical trials.
Further, printable tissues can eliminate unforeseeable variables in clinical trials for treatments, accelerating approval of new drugs.
The easily repeatable process can be customized to create other types of organs. This innovation has potential to impact in vitro tissue engineering, drug screening research, and animal testing.